{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T06:17:11Z","timestamp":1786947431981,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Analytica Chimica Acta"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.aca.2022.339978","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T16:15:33Z","timestamp":1653322533000},"page":"339978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Development of a non-radioactive mass spectrometry-based binding assay at the \u03bc-opioid receptor and its application for the determination of the binding affinities of 17 opiates\/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles"],"prefix":"10.1016","volume":"1219","author":[{"given":"Madeleine Ramona","family":"Volz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-6359","authenticated-orcid":false,"given":"Bjoern","family":"Moosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aca.2022.339978_bib1","series-title":"European Drug Report 2021: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addicition","year":"2021"},{"key":"10.1016\/j.aca.2022.339978_bib2","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1373\/clinchem.2017.274662","article-title":"Impact of novel psychoactive substances on clinical and forensic toxicology and global public health","volume":"63","author":"Huestis","year":"2017","journal-title":"Clin. Chem."},{"key":"10.1016\/j.aca.2022.339978_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"J. Addiction Med."},{"key":"10.1016\/j.aca.2022.339978_bib5","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.yrtph.2010.12.007","article-title":"Uniform assessment and ranking of opioid mu receptor binding constants for selected opioid drugs","volume":"59","author":"Volpe","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib6","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/add.14614","article-title":"How the complex pharmacology of the fentanyls contributes to their lethality","volume":"114","author":"Gill","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.aca.2022.339978_bib7","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acschemneuro.1c00064","article-title":"Synthesis, chemical characterization, and \u03bc-opioid receptor activity assessment of the emerging group of \u201cnitazene\u201d 2-benzylbenzimidazole synthetic opioids","volume":"12","author":"Vandeputte","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.aca.2022.339978_bib8","series-title":"WHO Expert Committee on Drug Dependence: Forty-Third Report","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.aca.2022.339978_bib9","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1021\/acschemneuro.1c00037","article-title":"DARK classics in chemical neuroscience: etonitazene and related benzimidazoles","volume":"12","author":"Ujv\u00e1ry","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.aca.2022.339978_bib10","doi-asserted-by":"crossref","first-page":"107561","DOI":"10.1016\/j.neuropharm.2019.03.004","article-title":"MS binding assays for GlyT1 based on Org24598 as nonlabelled reporter ligand","volume":"161","author":"Ackermann","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.aca.2022.339978_bib11","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1002\/cmdc.201100251","article-title":"(S)- and (R)-fluoxetine as native markers in mass spectrometry (MS) binding assays addressing the serotonin transporter","volume":"6","author":"Hess","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib12","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1002\/anie.200351806","article-title":"Competitive binding assays made easy with a native marker and mass spectrometric quantification","volume":"42","author":"H\u00f6fner","year":"2003","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.aca.2022.339978_bib13","series-title":"Analyzing Biomolecular Interactions by Mass Spectrometry","first-page":"165","article-title":"MS binding assays","author":"H\u00f6fner","year":"2015"},{"key":"10.1016\/j.aca.2022.339978_bib14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/cbic.200500074","article-title":"Competitive MS binding assays for dopamine D2 receptors employing spiperone as a native marker","volume":"6","author":"Niessen","year":"2005","journal-title":"Chembiochem"},{"key":"10.1016\/j.aca.2022.339978_bib15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/cmdc.200500038","article-title":"MS-binding assays: kinetic, saturation, and competitive experiments based on quantitation of bound marker as exemplified by the GABA transporter mGAT1","volume":"1","author":"Zepperitz","year":"2006","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib16","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cmdc.201500084","article-title":"MS binding assays for the three monoamine transporters using the triple reuptake inhibitor (1R,3S)-Indatraline as native marker","volume":"10","author":"Grimm","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/cmdc.201500084","article-title":"MS Binding Assays for the three monoamine transporters using the triple reuptake inhibitor (1R, 3S)\u2010indatraline as native marker","volume":"10","author":"Grimm","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib18","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cmdc.201700737","article-title":"Simultaneous multiple MS binding assays for the dopamine, norepinephrine, and serotonin transporters","volume":"13","author":"Neiens","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib19","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/cmdc.201500355","article-title":"MS binding assays for D1 and D5 dopamine receptors","volume":"10","author":"Neiens","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib20","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s11302-015-9477-0","article-title":"Mass spectrometry-based ligand binding assays on adenosine A 1 and A 2A receptors","volume":"11","author":"Massink","year":"2015","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.aca.2022.339978_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/2472555217719748","article-title":"Label-free, LC-MS-based assays to quantitate small-molecule antagonist binding to the mammalian BLT1 receptor","volume":"22","author":"Chen","year":"2017","journal-title":"SLAS Discov."},{"key":"10.1016\/j.aca.2022.339978_bib22","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/cmdc.201600447","article-title":"Quantitative MALDI-MS binding assays: an alternative to radiolabeling","volume":"11","author":"Rossato","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.aca.2022.339978_bib23","series-title":"Assay Guidance Manual","article-title":"Receptor binding assays for HTS and drug discovery","author":"Auld","year":"2018"},{"key":"10.1016\/j.aca.2022.339978_bib24","author":"Technical data sheet"},{"key":"10.1016\/j.aca.2022.339978_bib25","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Yung-Chi","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejphar.2008.09.043","article-title":"A pharmacological comparison of the cloned frog and human mu opioid receptors reveals differences in opioid affinity and function","volume":"599","author":"Brasel","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(83)90331-X","article-title":"[3H]Sufentanil, a superior ligand for \u03bc-opiate receptors: binding properties and regional distribution in rat brain and spinal cord","volume":"87","author":"Leysen","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0014-2999(79)90142-0","article-title":"Opiate receptor binding affected differentially by opiates and opioid peptides","volume":"55","author":"Childers","year":"1979","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib29","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1073\/pnas.77.8.4469","article-title":"Possible role of distinct morphine and enkephalin receptors in mediating actions of benzomorphan drugs (putative and \u03ba and \u03c3 agonists)","volume":"77","author":"Chang","year":"1980","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.aca.2022.339978_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned \u03ba-, \u03b4- , and \u03bc-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.aca.2022.339978_bib31","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0022-3565(25)20761-3","article-title":"Characterization of opioid agonist efficacy in a C6 Glioma cell line expressing the \u03bc opioid receptor","volume":"278","author":"Emmerson","year":"1996","journal-title":"J. Pharmacol. Exp. Therapeut."}],"container-title":["Analytica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267022005499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003267022005499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:47:20Z","timestamp":1757706440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003267022005499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":30,"alternative-id":["S0003267022005499"],"URL":"https:\/\/doi.org\/10.1016\/j.aca.2022.339978","relation":{},"ISSN":["0003-2670"],"issn-type":[{"value":"0003-2670","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a non-radioactive mass spectrometry-based binding assay at the \u03bc-opioid receptor and its application for the determination of the binding affinities of 17 opiates\/opioids as well as of the designer opioid isotonitazene and five further 2-benzylbenzimidazoles","name":"articletitle","label":"Article Title"},{"value":"Analytica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aca.2022.339978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"339978"}}